Employees department of Public Health



Professor H.J. de Koning MD, PhD, epidemiologist - click to enlarge
Professor H.J. de Koning MD, PhD, epidemiologist
Professor of Public Health & Screening Evaluation		Biography Research Interests Projects Publications Working papers Memberships Contact
Projects

Principal investigator
2nd budget source (all running projects)

    

EU Advanced Researcher Grant 

 

 

EU HORIZON 2020 

 


               

 

EU JA
                

 
NIH/NCI 

 

 

 



Research Councils 

 

 


 

The Netherlands

 

 

 

 

Principal investigator
Other external funding 

 

 

 

 

 

 

 

 

 

 
Co-investigator
2nd budget source

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 

 

Co-investigator
Other external funding

 • ROBINSCA: New and more individualised population-based screening for cardiovascular disease; from a RCT including self-assessments, primary care and coronary artery calcification score to modelling risk-benefit                                                         

• EU-TOPIA: Towards improved screening for breast, cervical and colorectal cancer in all of Europe (Coordinator)               

• EU-SCREEN: Implementation of optimized childhood vision and hearing screening programmes in middle-income countries in Europe (Substitute coordinator) 
        

• CANCON – European Guide on Quality Improvement in Comprehensive Cancer Control     

• CISNET – Comparative Modelling of Lung Cancer Prevention and Control Policies  (2005-2020)                

• CISNET - Modelling to Improve Prostate Cancer Outcomes Across Diverse Populations  (2005-2020)               

• CISNET – Comparative Modelling: Informing Breast Cancer Control Practice Policy  (2005-2020) 
           

• Research-based evaluation of the Norwegian Breast Cancer Screening Program (Norway Research Council)                

• Validation of the Erasmus MC MISCAN-Fadia model for cost-effectiveness analyses of mammography screening in Singapore (NMRC) 
           

• Dutch-Belgian (NELSON-) RCT on lung cancer screening by low dose spiral CT in high-risk subjects (ZonMw, KWF Kankerbestrijding)                

• MRI   screening trial for women with a high risk of breast cancer and analysis of its cost-effectiveness (ZonMw, KWF Kankerbestrijding)


                             

• Dutch nationwide breast cancer screening programme 1991-2017 (RIVM)                         

• Dutch nationwide cervical cancer screening programme 1991-2017 (RIVM)                          

• Dutch nationwide colorectal cancer screening programme 2014-2019 (RIVM)                     

• Health Technology Assessment for CT lung cancer screening including modelling of outcomes and cost-effectiveness (Sunnybrook Health Sciences, Toronto, Canada)                         

• SCOR Global Life. Forecast age specific incidences for DCIS (Carcinoma in situ of the breast) and invasive breast cancer for South Korea under the assumption of various screening scenarios

 

• HORIZON 2020 – ITN - A new era in personalised medicine: Radiomics as decision support tool for diagnostics and theragnostics in oncology (PREDICT) 2017 
• NIH BCSC/Dartmouth college – Risk-Based Breast Cancer Screening in Community Settings 

• NIH PO1 – Integrative analysis of lung cancer aetiology and risk 2017                         

• CISNET – Comparative Modelling of Colorectal Cancer: Informing Health Policies and Prioritizing Future Research (NIH/NCI, USA)                          

• CISNET - Comparative modelling to inform cervical cancer control policies (NIH/NCI, USA)                          

• European Randomised Study of Prostate cancer screening (ERSPC) (ZonMw, KWF Kankerbestrijding, Beckman, NCI)                          

• Screening of coeliac disease in the Preventive Youth Health Care Centres in the Netherlands (GLUTENSCREEN)  (ZonMw) 2017                          

• DENSE Trial: MR Imaging as an Additional Screening Modality for the Detection of Breast Cancer in Women Aged 50-75 Years with Extremely Dense Breasts (ZonMw)                          

• PRISMA (TOP-subsidy): breast cancer screening – from one-size-fits-all to a personalized risk-based approach (ZonMw)
                                               
                                                                                          
• EARLY-SYNERGY (Hartstichting) 2017                           

• Towards risk-stratified guidelines for surveillance and treatment of patients with Barrett's oesophagus (KWF Kankerbestrijding)                          

• Evaluating the long-term effectiveness and cost-effectiveness of population-based screening and treatment for prostate cancer: the CAP and ProtecT RCTs (Cancer Research UK)